Dr. Peter Lim
Claim this profileCenter of Hope
Studies Ovarian Cancer
Studies Ovarian Tumors
13 reported clinical trials
20 drugs studied
Area of expertise
1Ovarian Cancer
FRα positive
BRCA1
BRCA2
2Ovarian Tumors
FRα positive
BRCA1
BRCA2
Affiliated Hospitals
Clinical Trials Peter Lim is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 313 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Peter Lim
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Peter Lim has experience with
- Letrozole
- Mirvetuximab Soravtansine
- Bevacizumab
- ZN-c3
- Carboplatin
- Paclitaxel
Breakdown of trials Peter Lim has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Lim specialize in?
Peter Lim focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are BRCA1.
Is Peter Lim currently recruiting for clinical trials?
Yes, Peter Lim is currently recruiting for 6 clinical trials in Reno Nevada. If you're interested in participating, you should apply.
Are there any treatments that Peter Lim has studied deeply?
Yes, Peter Lim has studied treatments such as Letrozole, Mirvetuximab Soravtansine, Bevacizumab.
What is the best way to schedule an appointment with Peter Lim?
Apply for one of the trials that Peter Lim is conducting.
What is the office address of Peter Lim?
The office of Peter Lim is located at: Center of Hope, Reno, Nevada 89511 United States. This is the address for their practice at the Center of Hope.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.